Treatment of mild to moderate major depressive disorder with agomelatine in patients with cardiovascular disorders (national observational multicenter study "pulse")

被引：0
|
作者：
Medvedev, V.
机构：
来源：
EUROPEAN PSYCHIATRY | 2016年 / 33卷
关键词：
D O I：
10.1016/j.eurpsy.2016.01.1508
中图分类号：
R749 [精神病学];
学科分类号：
100205 ;
摘要：
EV523
引用
收藏
页码：S417 / S418
页数：2
相关论文
共 50 条
  • [1] Agomelatine in the treatment of mild-to-moderate depression in patients with cardiovascular disease: results of the national multicenter observational study PULSE
    Medvedev, Vladimir E.
    [J]. NEUROPSYCHIATRIC DISEASE AND TREATMENT, 2017, 13 : 1141 - 1151
  • [2] Agomelatine in the treatment of depressive disorders in clinical practice: multicenter observational CHRONOS study
    Ivanov, Stanislav V.
    Samushiya, Marina A.
    [J]. NEUROPSYCHIATRIC DISEASE AND TREATMENT, 2014, 10 : 631 - 639
  • [3] Agomelatine in pediatric patients with moderate to severe major depressive disorder: an open-label extension study
    Arango, Celso
    Fegert, Joerg M.
    Picarel-Blanchot, Francoise
    Marx, Ute
    Truffaut-Chalet, Lucie
    Penelaud, Pierre-Francois
    Buitelaar, Jan
    [J]. EUROPEAN CHILD & ADOLESCENT PSYCHIATRY, 2024,
  • [4] EFFICACY AND SAFETY OF AGOMELATINE IN TREATMENT OF MAJOR DEPRESSIVE DISORDER: A PILOT STUDY
    Nukala, Srikrishna
    Komaram, Ravi Babu
    Palla, Jayasree
    Murthy, K. S. N.
    [J]. INTERNATIONAL JOURNAL OF PHARMACEUTICAL SCIENCES AND RESEARCH, 2016, 7 (08): : 3517 - 3521
  • [5] A comparative prospective study of agomelatine versus escitalopram in treatment of severe major depressive disorder
    Petrescu, B.
    Vasile, D.
    Vasiliu, O.
    Mangalagiu, A. G.
    Tudor, C.
    Ungureanu, D.
    [J]. EUROPEAN NEUROPSYCHOPHARMACOLOGY, 2015, 25 : S439 - S439
  • [6] Agomelatine Versus Venlafaxine XR in the Treatment of Anhedonia in Major Depressive Disorder A Pilot Study
    Martinotti, Giovanni
    Sepede, Gianna
    Gambi, Francesco
    Di Iorio, Giuseppe
    De Berardis, Domenico
    Di Nicola, Marco
    Onofrj, Marco
    Janiri, Luigi
    Di Giannantonio, Massimo
    [J]. JOURNAL OF CLINICAL PSYCHOPHARMACOLOGY, 2012, 32 (04) : 487 - 491
  • [7] OPEN TRIAL STUDY TREATMENT WITH AGOMELATINE IN ELDERLY PATIENTS WITH MAJOR DEPRESSIVE DISORDER WITH HYPONATREMIA DUE TO SSRI USE
    Alberto De La Garza, Luis
    Gogeascoechea-Hernandez, Andoni
    Ontiveros-Sanchez de la Barquera, Jose Alfonso
    Sanchez-Torres, Guillermo
    Jezzini-Martinez, Sofia
    Porras-Garza, Guillermo
    Zarate-Garza, Patricio
    [J]. AMERICAN JOURNAL OF GERIATRIC PSYCHIATRY, 2024, 32 (04): : S99 - S100
  • [8] Agomelatine in the Treatment of Major Depressive Disorder: An 8-Week, Multicenter, Randomized, Placebo-Controlled Trial
    Stahl, Stephen M.
    Fava, Maurizio
    Trivedi, Madhukar H.
    Caputo, Angelika
    Shah, Amy
    Post, Anke
    [J]. JOURNAL OF CLINICAL PSYCHIATRY, 2010, 71 (05) : 616 - 626
  • [9] Cardiovascular risk factors may moderate pharmacological treatment effects in major depressive disorder
    Iosifescu, DV
    Clementi-Craven, N
    Fraguas, R
    Papakostas, GI
    Petersen, T
    Alpert, JE
    Nierenberg, AA
    Fava, M
    [J]. PSYCHOSOMATIC MEDICINE, 2005, 67 (05) : 703 - 706
  • [10] Clinical characteristics and treatment outcomes of patients with major depressive disorder and comorbid anxiety disorders - results from a European multicenter study
    Dold, Markus
    Bartova, Lucie
    Souery, Daniel
    Mendlewicz, Julien
    Serretti, Alessandro
    Porcelli, Stefano
    Zohar, Joseph
    Montgomery, Stuart
    Kasper, Siegfried
    [J]. JOURNAL OF PSYCHIATRIC RESEARCH, 2017, 91 : 1 - 13
12345